Efficacy and Safety of a Novel Gene Therapy (URO-902; PVAX/HSLO) in Female Patients With Overactive Bladder and Urge Urinary Incontinence: Results From a Phase 2A Trial.
Conference Proceeding - Restricted Access
Journal of Urology
Peters K, Enemchukwu E, Kalota S, Robertson K, Greene H, Badger H, et al. Efficacy and safety of a novel gene therapy (URO-902; PVAX/HSLO) in female patients with overactive bladder and urge urinary incontinence: results from a phase 2A trial. J Urol. 2022 May;207(Suppl 5):e1048. doi:10.1097/JU.0000000000002671.03.